Roche’s bid to retool Actemra for COVID-19 fails
Roche launched the 330-patient trial in March as it joined other pharmaceutical companies seeking to… Read More
5 years ago
Roche
Pharma wins US nod for COVID-19 antibody test
Roche’s head of diagnostics, said the company aims to more than double production of tests… Read More
5 years ago
New flu drug can drive resistance in influenza viruses
The Swiss drugmaker is seeking to establish Xofluza, which has a list price of $150,… Read More
5 years ago
Pharma firm wins approval for personalised cancer drug
Roche is also testing Rozlytrek in cancers with additional genetic anomalies Read More
6 years ago
Roche sues US executives in fight over diabetes test strips
Roche is seeking damages and compensation in a U.S. lawsuit against former executives of a… Read More
6 years ago
Roche, joining rivals, donates hemophilia drug to boost access
Roche’s donation will focus on patients who have developed resistance, or inhibitors, to current hemophilia… Read More
6 years ago
Roche CEO says new drugs will offset biosimilar incursions
ZURICH: Swiss drugmaker Roche will be able to compensate or overcompensate for falling revenue from… Read More
7 years ago
Roche’s emicizumab haemophilia drug succeeds in trial
SHANGHAI: Roche Holding AG's emicizumab drug for treating haemophilia A showed it worked in a… Read More
8 years ago
Roche lung cancer drug success adds to pressure on Bristol
COPENHAGEN: Lung cancer patients on Roche's immune system-boosting drug Tecentriq lived on average 4.2 months… Read More
8 years ago
Roche to buy U.S. biotech firm InterMune for $8.3 billion
LONDON/ZURICH: Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3… Read More
11 years ago